@article {8066,
	title = {Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group},
	journal = {British Journal of Haematology},
	volume = {121},
	year = {2003},
	note = {Cited By :1372Export Date: 21 February 2017},
	month = {2003},
	pages = {749 - 757},
	abstract = {The monoclonal gammopathies are a group of disorders associated with monoclonal proliferation of plasma cells. The characterization of specific entities is an area of difficulty in clinical practice. The International Myeloma Working Group has reviewed the criteria for diagnosis and classification with the aim of producing simple, easily used definitions based on routinely available investigations. In monoclonal gammopathy of undetermined significance (MGUS) or monoclonal gammopathy, unattributed/unassociated (MG[u]), the monoclonal protein is < 30 g/1 and the bone marrow clonal cells < 10\% with no evidence of multiple myeloma, other B-cell proliferative disorders or amyloidosis. In asymptomatic (smouldering) myeloma the M-protein is >= 30 g/1 and/or bone marrow clonal cells >= 10\% but no related organ or tissue impairment (ROTI)(end-organ damage), which is typically manifested by increased calcium, renal insufficiency, anaemia, or bone lesions (CRAB) attributed to the plasma cell proliferative process. Symptomatic myeloma requires evidence of ROTL Non-secretory myeloma is characterized by the absence of an M-protein in the serum and urine, bone marrow plasmacytosis and ROTI. Solitary plasmacytoma of bone, extramedullary plasmacytoma and multiple solitary plasmacytomas ({\textpm} recurrent) are also defined as distinct entities. The use of these criteria will facilitate comparison of therapeutic trial data. Evaluation of currently available prognostic factors may allow better definition of prognosis in multiple myeloma.},
	keywords = {classification, Gammopathies, Monoclonal, multiple myeloma},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038509089\&doi=10.1046\%2fj.1365-2141.2003.04355.x\&partnerID=40\&md5=ee4eb1e1669c253b3c6c1df03b0d17b0},
	author = {Kyle, R.A. and Child, J.A. and Anderson, K. and Barlogie, B. and Bataille, R. and Bensinger, W. and Blad{\'e}, J. and Boccadoro, M. and Dalton, W. and Dimopoulos, M. and Djulbegovic, B. and Drayson, M. and Durie, B. and Facon, T. and Fonseca, R. and Gahrton, G. and Greipp, P. and Harousseau, J.L. and Harrington, D. and Hussein, M. and Joshua, D. and Ludwig, H. and Morgan, G. and Oken, M. and Powles, R. and Richardson, P. and Roodman, D. and San Miguel, J. and Shimizu, K. and Shustik, C. and Sirohi, B. and Sonneveld, P. and Tricot, G. and Turesson, I. and Van Ness, B. and Vesole, D. and Weber, D. and Westin, J. and Wheatley, K.}
}
